Q4 Activity Finishes Off Stronger Biopharma M&A Year In 2025

 
• By Joseph Haas
  
M&A
Q4 data from Evaluate Pharma show 2025 finished with a stronger M&A trend than 2024 (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business